The institute of
Advanced ultrasound
guided procedures
Note: SX-One MicroKnife has been renamed UltraGuideCTR. The device, intended use, indications for use, and clinical data regarding safety and effectiveness are the same.
Ashley L. Pistorio, Paul D. Paterson, James F. Watt, Johnny T. Nelson, Randall D. Alexander, Richard J. Post, Larry E. Miller, Victor M. Marwin
Plastic and Reconstructive Surgery Global Open. 2026;14(8),e8054. https://doi.org/10.1097/GOX.0000000000008054
Two-year results of a prospective, multicenter, single-arm study of office-based UGCTR performed at 7 centers. The primary purpose was to document the long-term results of the previously published 6-month paper (Pistorio et al. JHS-GO 2024). 2-year follow-up was available on 92.6% of patients (138 patents/210 hands) and demonstrated durability of improvements at 2-years, 95.7% satisfaction, and no revisions for recurrence. Sub-analysis demonstrated similar long-term results for simultaneous bilateral releases and unilateral releases. This follow-up publication also reported that 51.7% of patients had sonographically severe disease, and the 7 investigators had performed a median of 11 procedures prior to the study, with over half having no or little office-based UGCTR experience (3/7 had no experience and 1/7 had performed 1 office-based UGCTR procedure).
Marin S. Smith, Xiaoning Yuan, J. Banks Deal Jr., George P. Nanos III, Scott M. Tintle, Nelson A. Hager, David E. Reece, Matthew E. Miller
Journal of Hand Surgery Global Online. 2026 Jun 29;8(5):101078. doi: 10.1016/j.jhsg.2026.101078. PMID: 42404100; PMCID: PMC13331985
Prospective, randomized, controlled trial from the Walter Reed National Military Center comparing 21 patients treated with CTR-US in a clinic setting to 20 patients treated with mOCTR. CTR-US procedures represented the first clinical procedures performed by trained PM&R physicians, whereas all mOCTR procedures were performed by experienced hand surgeons. Follow-up at 2-years was 100%. CTR-US patients had significantly smaller incisions (5.4mm vs. 28.0mm) and used less opioids in the early post-operative period (although few opioids were used in either group). Both groups exhibited significant and clinically meaningful improvements in BCTQ-SSS, QDASH, and pain scores by 1-month which were sustained at 2-years, without significant differences between-group differences. The CTR-US group reported significantly less incisional pain and functionally limiting incisional pain during the first 3-4 weeks post-procedure. One infection was reported in a CTR-US patient. The authors concluded that CTR-US and mOCTR both resulted in significant and clinically meaningful improvements in symptoms and function that were durable at 2-years in a military population. CTR-US provided early advantages with respect to wound pain and functionally limiting wound pain.
Victor M. Marwin, Stuart M. Hilliard, James F. Watt, John J. Callahan, Paul E. Perry, Alan J. Micev, Larry E. Miller, Johnny T. Nelson
Journal of Hand Surgery Global Online. 2026 Jun 5;8(4):101063. doi: 10.1016/j.jhsg.2026.101063. PMID: 42292900; PMCID: PMC13264358
Large case series from the MISSION post-market registry. 887 patients/1082 hands with both baseline and 6-month post-operative data following UGCTR using UltraGuideCTR performed by 22 different physicians. Nearly 50% of patients had symptoms for 2 years or longer, 57.2% had sonographically severe CTS, and many patients had comorbidities. Wide-awake local anesthesia was used in 82.1% of patients, average incision size was 5mm, and 22% (195 patients) had simultaneous bilateral releases. Median return to normal activities was 3 days and median return to work was 4 days, including 115 heavy manual laborers who returned to work at a median of 5 days. At 6 months, BCTQ-SSS/-FSS, pain, and EQ-5D-5L significantly improved versus baseline, with 89.9% patient satisfaction. One patient was revised at 6 months for scar tissue, and no major adverse events were reported. Results of simultaneous bilateral releases were similar to unilateral releases. Overall results were consistent with previous studies, including Aguila et al. (APEX-CTR Registry)
Victor M. Marwin, Johnny T. Nelson, James F. Watt, James R. Verheyden, Paul E. Perry, Lance G. Warhold, David J. Carl, M.J. Palmer, Steven R. Niedermeier, Larry E. Miller, Jenna M. Godfrey
Journal of Hand Surgery Global Online. 2026 Feb 27;8(3):100974. doi: 10.1016/j.jhsg.2026.100974. PMID: 41799667; PMCID: PMC12966659
Propensity-matched comparison of 186 UGCTR patients and 186 ECTR patients from the MISSION post-market registry. Compared to ECTR, UGCTR was more likely to be performed using only local anesthesia (85.5% vs. 57.5%) and was associated with smaller incisions (5mm vs. 12mm), less suture closure (11% vs. 100%), less opioid use (10.3% vs. 39.7%), and superior 3-month BCTQ-SSS/-FSS scores, pain scores, quality of life scores, overall satisfaction and wound satisfaction. One ECTR patient was revised due to an incomplete release. No serious adverse events occurred in either group during the 3-month follow-up.
Victor M. Marwin, Christopher J. Lincoski, Johnny T. Nelson, James F. Watt, Amy T. Moeller, Paul E. Perry MD, Nicholas A. Bontempo, Steven R. Niedermeier, Larry E. Miller, Kyle J. Moyles
Journal of Hand Surgery Global Online. 2026 Jan 21;8(2):100931. doi: 10.1016/j.jhsg.2025.100931. PMID: 41624979; PMCID: PMC12859246
Propensity-matched comparison of 178 UGCTR patients and 178 OCTR patients from the MISSION post-market registry. Compared to OCTR, UGCTR was more likely to be performed using only local anesthesia (84.8% vs. 19.1%) and was associated with smaller incisions (5.2mm vs. 16.5mm), less suture closure (14.6% vs. 100%), less opioid use (10.2% vs. 49.1%), and superior 3-month BCTQ-SSS/-FSS scores, pain scores, and wound satisfaction. No serious adverse events or reoperations occurred in either group during the 3-month follow-up.
Logan Cano, Braeden M. Leiby, Laura C. Shum, Meliza G. Ward, Anthony E. Joseph
Journal of Hand Surgery Global Online, 2024;6:354-59. ISSN 2589-5141, https://doi.org/10.1016/j.jhsg.2024.02.004
Case series reporting the results of 102 patients/162 hands at a minimum of 2-years following carpal tunnel release using ultrasound guidance (CTR-US) and UltraGuideCTR performed by a single physician in a community-based practice. Over 50% of the patients were treated with simultaneous bilateral releases. At a mean final follow-up of 46 months (range 2-6 years) BCTQ-SSS/-FSS and QDASH scores remained significantly improved vs. baseline (P<0.001) and improvements exceeded minimal clinically important differences. Mean patient satisfaction scores were 4.6 (1-5 scale) with 91.2% of patients reported being satisfied or very satisfied with the procedure. There were no re-operations for recurrence. Results were similar for patients treated with unilateral vs. simultaneous bilateral releases.
Kyle R. Eberlin, Benjamin P. Amis, Thomas P. Berkbigler, Christopher J. Dy, Mark D. Fischer, James L. Gluck, F. Thomas D. Kaplan, Thomas J. McDonald, Larry E. Miller, Alexander Palmer, Paul E. Perry, Marc E. Walker, James F. Watt
Plastic and Reconstructive Surgery Global Open. 2024;12(3):e5665. Published 2024 Mar 4. doi:10.1097/GOX.0000000000005665. PMID: 38440365; PMCID: PMC10911521
One-year results of a multicenter, prospective randomized trial of CTR-US using UltraGuideCTR vs. mOCTR. Primary purpose was to report the final, one-year outcomes in follow-up to the previous publication of Eberlin et al. (Expert Rev Med Devices 2023). One-year follow-up was available in 80/94 and 27/28 subjects treated with CTR-US and mOCTR, respectively. At 1-year, mean improvements in BCTQ-SSS/-FSS, numerical pain, and EQ-5D-5L scores remained significantly improved vs. baseline (P<0.001) and exceeded minimal clinically important differences. 95% of CTR-US subjects reported satisfaction with the procedure vs. 92.6% of mOCTR subjects. Incisions were significantly smaller for the CTR-US group (mean 6mm in the wrist vs. 22 mm in the palm, P<0.001) and at year significantly more CTR-US subjects reported freedom from scar pain or sensitivity (95% vs. 74.1%, P=0.005). There were no recurrences or late complications in either group.
Paul D. Paterson, Matthew J. Kirsch, Larry E. Miller, Demetrio J. Aguila, III
Plastic and Reconstructive Surgery Global Open. 2024;12(2):e5647. Published 2024 Feb 27. doi:10.1097/GOX.0000000000005647
Case series from the APEX-CTR multicenter, post-market registry reporting return to work (RTW) for 544 patients/655 hands treated with CTR-US using UltraGuideCTR at 24 centers. In this real-world, pragmatic study, over half of patients (52%) had symptoms for >2 years and there were no restrictions based on maximum patient age, comorbidities (e.g., anxiety 21%, depression 19%, thyroid disease 12%) or tobacco use status (12% current tobacco use). All patients were employed at the time of surgery (49% desk-based, 28% light-manual, 23% heavy manual), with 45% reporting regular lifting of 20lbs or more, 19% reporting regular use of vibrating equipment and 18% reporting regular use of heavy equipment. Median RTW was 3 days and was 2-4 days for all job duty groups, including heavy manual laborers. Males and those in desk-based positions had a statistically significantly higher chance of returning to work within 5 days (P=0.01 and P<0.001, respectively). Complications included 2 deep infections, 2 revisions for persistent symptoms and one suspected tendon injury lost to follow-up (some complications were also reported in previous publications from the same registry).
Ashley L. Pistorio, Victor M. Marwin, Paul D. Paterson, Randall D. Alexander, Johnny T. Nelson, Larry E. Miller
Journal of Hand Surgery Global Online, 2024;6:273-279. ISSN 2589-5141, https://doi.org/10.1016/j.jhsg.2023.12.005
Six-month results of a prospective, multicenter, observational study reporting clinical outcomes of 149 subjects/226 hands treated with CTR-US using UltraGuideCTR in an office-based setting. All procedures were completed in the office using only local anesthesia (79% with epinephrine), >50% of subjects had simultaneous bilateral releases, and 3 of the 7 hand surgeons had no previous experience performing CTR-US in the office setting. All procedures were completed as planned, the mean intra-operative pain score was 1.9 (79% of subjects identified the needle stick as most painful), the mean incision length was 5 mm, and over 98% of wounds were closed without sutures. Median return to normal daily activities was 2 days and median return to work was 4 days (104 employed subjects), including heavy manual laborers. BCTQ-SSS/-FSS, MHQ, pain, and EQ-5D-5L scores rapidly improved and at 6-months remained significantly improved vs. baseline (P<0.001) and exceeded minimal clinically important differences. 94% of subjects were satisfied at 6 months and results were similar for simultaneous bilateral vs. unilateral procedures. No infections or revision surgeries for persistent or recurrent symptoms. One subject with increased paresthesias was explored, treated for a nerve contusion with a small epineurial injury, and had “complete recovery of median nerve function and minimal residual ring finger tingling” at 7 weeks.
Demetrio Aguila, Matthew Kirsch, Brett Kindle, Paul Paterson
Journal of Hand Surgery Global Online. 2023 Nov 22;6(1):79-84. doi: 10.1016/j.jhsg.2023.10.001. PMID: 38313613; PMCID: PMC10837292
Reports the final, 1-year results from the APEX-CTR post-market registry in follow-up to the previous publication of Fowler et al. (Expert Rev Med Devices 2022). 300 patients/341 hands had both pre-operative and 1-year post-operative data following CTR-US using UltraGuideCTR performed by 25 different physicians. At 1-year post-CTR-US, BCTQ-SSS/-FSS and QDASH scores remained significantly improved vs. baseline (P<0.001) and improvements exceeded minimal clinically important differences. 87.7% of patients were satisfied with the procedure, and the mean procedure recommendation score was 8.9 (0-10 scale). Females had a quantitatively small but statistically significantly greater improvement in BCTQ and QDASH scores. No other factors, including treatment with simultaneous releases or concomitant procedures (e.g., trigger finger release, cubital tunnel release), significantly affected 1-year outcomes. Complications included two revisions (one of which was also reported in Fowler et al.), 1 deep infection and 1 suspected tendon injury lost to follow-up.
Grace E. Nicholas, Jen Galloway, Jennifer Hawley, Joseph C. McGinley
Journal of Hand Surgery Global Online, 2023 Jun 7;5(5):595-600. doi: 10.1016/j.jhsg.2023.05.002. PMID: 37790816; PMCID: PMC10543793
Consecutive case series of 65 patients/96 hands treated with CTR-US using UltraGuideCTR in a procedure room setting, including 13 patients/17 hands with pre- and post-operative MRI scans at a mean of 3 months post-op. No complications. Statistically significant improvements in BCTQ and QDASH scores occurred by 2 weeks, were maintained at 3–6-month follow-up, and exceeded minimal clinically important differences. All 38 employed patients with return to work data had returned to work by 2 weeks, including 21 manual laborers. MRI revealed complete TCL transection in all 17 wrists, and statistically significant changes in MRI parameters consistent with carpal tunnel decompression – 22% increase in carpal tunnel cross sectional area at the hamate, 52% increase in median nerve cross sectional area at the hamate, 18% reduction in median nerve T2 signal intensity, and 38% reduction in median nerve flattening (i.e., flattening ratio).
Kyle R. Eberlin, Benjamin P. Amis, Thomas P. Berkbigler, Christopher J. Dy, Mark D. Fischer, James L. Gluck, F. Thomas D. Kaplan, Thomas J. McDonald, Larry E. Miller, Alexander Palmer, Paul E. Perry, Marc E. Walker, James F. Watt
Expert Review of Medical Devices. 2023;20(7):597-605. doi:10.1080/17434440.2023.2218548
Three-month outcomes of a multicenter, prospective randomized trial of CTR-US using UltraGuideCTR vs. mOCTR. Both procedures at each site were performed by the same surgeon. Surgeon experience was significantly greater for mOCTR (median 1,000 procedures) vs. CTR-US (median 12 procedures). Thirteen patients randomized to mOCTR refused treatment and 46 declined to consent due to the possibility of randomization to mOCTR. Post-operative care was standardized. Mean incision length (6 mm vs. 22 mm) and freedom from wound sensitivity (61% vs. 18%) favored CTR-US. Both groups experienced statistically significant and clinically meaningful improvements in BCTQ, pain, and Euro-QOL scores, with no significant differences between the groups. The adverse event rate was also similar between the two groups (2.1% CTR-US vs. 3.6%).
Russell A. Bergum, Mark R. Ciota
Cureus. 2022 Jul 23;14(7):e27169. doi: 10.7759/cureus.27169. PMID: 35898805; PMCID: PMC9308387
Prospective case series of 88 patients (123 hands) with minimum 1-year follow-up following CTR-US using UltraGuideCTR. All procedures were confirmed by electrodiagnostic studies, and 2/3 of hands were moderately-severe or severe. All procedures were performed in an office-based procedure room using only local anesthesia and 46% of hands were treated as simultaneous bilateral procedures. Patients experienced statistically and clinically significant improvements in BCTQ-SSS, BCTQ-FSS and QDASH scores by 1-2 weeks post-procedure that persisted at 1 year. No intra-operative complications occurred; no conversions or supplementary analgesic medications were required. There were no neurovascular injuries, infections, or recurrences. One patient developed complex regional pain syndrome in the early post-operative period which was successfully treated; the patient subsequently had the contralateral hand treated with CTR-US without complication.
John R. Fowler, Kevin C. Chung, Larry E. Miller
Expert Review of Medical Devices. 2022 Mar;19(3):273-280. doi: 10.1080/17434440.2022.2048816. Epub 2022 Mar 10. PMID: 35236202
Multicenter pragmatic study of 373 patients/427 hands with 6-month follow-up following CTR-US using UltraGuideCTR. Procedures were performed at 24 different sites, 88% were performed using only local anesthesia and 25% of hands were performed as simultaneous bilateral procedures. Nearly 2/3 of physicians had performed <20 procedures prior to first patients enrolling in the database. QDASH, BCTQ-SSS and BCTQ-FSS scores were significantly improved by 2 weeks, continued to improve throughout the 6-month follow-up, and exceeded minimal clinically important differences. Median return to normal activities was 3 days, and median return to work was 5 days (48% of working patients were manual laborers), both of which compared favorably to historical controls for OCTR/mOCTR. No neurovascular complications occurred. One patient had revision surgery due to persistent symptoms attributed to an incomplete release.
Braeden M. Leiby, John P. Beckman, Anthony E. Joseph
HAND. 2022;17(6):1074-1081. doi: 10.1177/1558944720988080
Prospective case series of 47 patients (76 hands) with minimum 1-year follow-up. Nearly 1/3 of all hands with preoperative electrodiagnostic testing were graded as severe and over 70% of patients had one or more co-morbidities. 25 patients (50 hands) had bilateral simultaneous releases. Patients experienced statistically and clinically significant improvements in BCTQ-SSS, BCTQ-FSS and QDASH scores by 1-2 weeks post-procedure that persisted at 1 year. No complications occurred and there were no recurrences.
Sarah I. Kamel, Bradley Freid, Corbin Pomeranz, Ethan J. Halpern, Levon N. Nazarian
American Journal of Roentgenology. 2021 Aug;217(2):460-468. doi: 10.2214/AJR.20.24383
Case series of 61 wrists in 46 patients for which > 1-year follow-up was available on 55 wrists/40 patients. All cases were performed using local anesthesia in a clinic procedure room. Patients experienced statistically and clinically significant improvements in QDASH and BCTQ scores by 2- weeks post-procedure, which persisted at a median follow-up of 1.7 years (1.0-2.8 years). Two patients lost to follow up at 1 year had re-operations, one for post-traumatic wound dehiscence with subsequent infection and one for possible compartment syndrome following racquet sport participation. In the latter case, surgical exploration revealed compression of the median nerve by the distal forearm fascia.
Craig D. Chappell, John P. Beckman, Brian C. Baird, Amanda V. Takke
Journal of Ultrasound in Medicine 2020;39: 693-702. PMID: 31659789 DOI: 10.1002/jum.15146
Report of 37 wrists in 23 consecutive patients treated with CTR-US using UltraGuideCTR. All procedures were performed in an office procedure room using only local anesthesia (WALANT). No complications occurred. The authors reported statistically significant reductions in median nerve cross-sectional area, as well as statistically and clinically significant improvements in BCTQ scores at 6-10 weeks post-release. Although the primary endpoint of the study was the change in median nerve cross sectional area at 6-10 weeks, statistically significant reductions in nerve CSA and BCTQ scores were also observed as early as 2-4 weeks post-release.
Anthony E. Joseph, Braeden M. Leiby, John P. Beckman
Journal of Ultrasound in Medicine 2020;39: 441-52. PMID: 31449326 DOI: 10.1002/jum.15120
Three-month follow-up on 35 wrists in 22 consecutive patients treated with treated with CTR-US using UltraGuideCTR, including 11 patients treated with simultaneous bilateral releases. The authors reported no complications and there were statistically and clinically significant improvements in QDASH and BCTQ scores within 1-2 weeks post-release.
Troy Henning, Lynda Yang, Tariq Awan, Daniel Leuders, Adam M. Pourcho
Journal of Ultrasound in Medicine 2018;37:2699-706. doi: 10.1002/jum.14618
Clinical experience at the University of Michigan reporting on 18 wrists in 14 patients, including several patients with disabilities who were able to immediately use their crutches and wheelchairs. Multiple cases were performed in the office setting using only local anesthesia. The authors reported no neurovascular complications and excellent clinical outcomes.
Erek W. Latzka, P. Troy Henning, Adam M. Pourcho
PM&R 2018;10(10):1934-1482. doi: 10.1016/j.pmrj.2018.02.018
Case report documenting clinical improvement and reduction in median nerve cross- sectional area following CTR using the SX-One MicroKnife® with ultrasound guidance.
Troy Henning, Daniel Lueders, Kate Chang, Lynda Yang
PM&R 2018; 10(10):1115-1118. doi: 10.1016/j.pmrj.2018.02.016
Case report documenting the clinical outcome of a patient with post-polio syndrome who could immediately resume crutch weightbearing following CTR-US using UltraGuideCTR.